SYDNEY - The maker of the flu vaccine now implicated in a rash of child sickness across Australia - and possibly one toddler's death - has ruled out a "bad batch" is involved.
A spokesperson for Melbourne-based pharmaceutical company CSL says a check of available batch numbers listed on adverse
reaction reports had indicated no single batch could be responsible.
West Australian health authorities have now received more than 250 reports of child sickness linked to the vaccine.
GPs nationwide have been told to temporarily stop administering the vaccine to children aged under five.
"CSL is continuing to work with the Therapeutic Goods Administration (TGA) and WA Health to urgently investigate the adverse event reports," the CSL spokesperson said.
The spokesperson said CSL was now working to finalise numbers on how many doses of its Fluvax vaccine were sent to WA.
WA was the only state to offer a specific programme offering the injections for free to healthy children under five, which may account for its higher rate of adverse reactions compared to other states.
The lack of a problematic batch indicates that other factors - such as practices at immunisation clinics - are likely to be drawn into the TGA's investigation.
WA started its pediatric vaccination programme on March 19, and related adverse reactions among children have included vomiting and high fever leading to fits or convulsions.
A 1-year-old girl remains in a serious but stable condition in Perth's Princess Margaret Hospital after receiving the vaccine.
Queensland's coroner is also investigating the tragic case of toddler Ashley Jade Epapara, a 2-year-old who was found dead in her cot on April 9 just 12 hours after receiving the seasonal flu vaccine.
All states and territories have been asked to provide data on other possible cases of adverse reactions in children, though a TGA spokesperson said the problem appeared to be centred on WA.
Seasonal flu vaccines are made available ahead of every Australian winter, and their make-up is dictated by the World Health Organisation.
These vaccines are trivalent in that they offer protection against three influenza virus strains expected to be in circulation.
This year's seasonal flu vaccine offers protection against the A(H1N1) swine flu, along with an Influenza B strain and an A(H3N2) virus.
CSL is the major distributor and the only Australian-based maker of the vaccine though versions can also be imported into Australia by rival pharmaceutical companies.
Queensland's chief health officer Dr Jeannette Young says an initial autopsy has shown no sign that the vaccine was to blame for Ashley Epapara's death.
Ashley was found dead in her cot on April 9, a day after she and her twin sister were given the seasonal flu vaccination by a private Brisbane GP.
Queensland Health Minister Paul Lucas said that so far there had been 41 adverse reactions to the seasonal flu vaccine in Queensland, including 15 in children under five.
Lucas said there'd been 209 adverse reactions to swine flu but did not specify how many involved young children.
- AAP
Reports of child sickness linked to the vaccine are rolling in. Photo / Christchurch Star
SYDNEY - The maker of the flu vaccine now implicated in a rash of child sickness across Australia - and possibly one toddler's death - has ruled out a "bad batch" is involved.
A spokesperson for Melbourne-based pharmaceutical company CSL says a check of available batch numbers listed on adverse
AdvertisementAdvertise with NZME.